We are live on ! Find out more
PMD

Psychemedics Corporation
PMD

Delisted

PMD was delisted on the 12th of December, 2024.

Back to rankings

21 hedge funds and large institutions have $9.55M invested in Psychemedics Corporation in 2022 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 6 increasing their positions, 7 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

13% less capital invested

Capital invested by funds: $11M → $9.55M (-$1.42M)

14% less repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 7

16% less funds holding

Funds holding: 25 → 21 (-4)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 3

Holders
21
Holders Change
-4
Holders Change %
-16%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
6
Reduced
7
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$90.6K
2
CC
Cannell Capital
Wyoming
+$69.9K
3
WE
Wealth Effects
Massachusetts
+$34K
4
CIC
Crawford Investment Counsel
Georgia
+$5.17K
5
Geode Capital Management
Geode Capital Management
Massachusetts
+$4.39K

Top Sellers

1
ICM
Invenomic Capital Management
Massachusetts
-$590K
2
Renaissance Technologies
Renaissance Technologies
New York
-$97.7K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$83K
4
HWM
HighMark Wealth Management
Minnesota
-$14K
5
Northern Trust
Northern Trust
Illinois
-$9.03K
Name Holding Trade Value Shares
Change 		Change in
Stake
Renaissance Technologies
1
Renaissance Technologies
New York
$2.07M -$97.7K -15,255 -4%
CIC
2
Crawford Investment Counsel
Georgia
$1.7M +$5.17K +807 +0.3%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.57M – – –
RC
4
RBF Capital
California
$952K – – –
CC
5
Cannell Capital
Wyoming
$566K +$69.9K +10,905 +14%
BlackRock
6
BlackRock
New York
$552K -$9.03K -1,409 -2%
AA
7
Ancora Advisors
Ohio
$512K – – –
Dimensional Fund Advisors
8
Dimensional Fund Advisors
Texas
$379K -$3.06K -478 -0.8%
WE
9
Wealth Effects
Massachusetts
$287K +$34K +5,300 +13%
ICM
10
Invenomic Capital Management
Massachusetts
$276K -$590K -92,071 -68%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$223K +$4.39K +686 +2%
SMP
12
Santa Monica Partners
Florida
$127K – – –
Morgan Stanley
13
Morgan Stanley
New York
$122K +$90.6K +14,141 +282%
Northern Trust
14
Northern Trust
Illinois
$110K -$9.03K -1,410 -8%
State Street
15
State Street
Massachusetts
$102K – – –
TRCT
16
Tower Research Capital (TRC)
New York
$7K -$2.47K -385 -25%
UBS Group
17
UBS Group
Switzerland
$3K -$7.92K -1,236 -71%
Fidelity Investments
18
Fidelity Investments
Massachusetts
$1K – – –
NFSG
19
Newbridge Financial Services Group
Florida
$1K – – –
NSIM
20
North Star Investment Management
Illinois
$1K – – –
Susquehanna International Group
21
Susquehanna International Group
Pennsylvania
– -$83K -11,910 Closed
HWM
22
HighMark Wealth Management
Minnesota
– -$14K -2,039 Closed
Citigroup
23
Citigroup
New York
– -$3K -500 Closed
Wells Fargo
24
Wells Fargo
California
– +$19 +3 +10%

PMD Hedge Fund Activity: Q2 2022 in Review

21 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Psychemedics Corporation (PMD) for Q2 2022, worth a combined $9.55M — down 13% from $11M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PMD and 0 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 6 added.

The largest buyer was Morgan Stanley, adding an estimated $90.6K. The largest seller was Invenomic Capital Management, cutting an estimated $590K.

  • 21 institutional investors held Psychemedics Corporation (PMD) as of Q2 2022, down from 25 in Q1 2022.
  • Funds reported $9.55M of Psychemedics Corporation stock for Q2 2022, down 13% quarter-over-quarter.
  • 0 funds opened new Psychemedics Corporation positions in Q2 2022 and 3 closed out, a net change of -3 holders.
  • The largest Psychemedics Corporation buyer in Q2 2022 was Morgan Stanley, an estimated $90.6K added.
  • The largest Psychemedics Corporation seller in Q2 2022 was Invenomic Capital Management, an estimated $590K sold.

Based on aggregated 13F filings for Q2 2022.